Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513.SS) SHH

Currency In CNY

AD

Valuation

Market Cap5.23B
Enterprise Value6.59B
P/E Ratio-80.63
PEG Ratio0.85
Price/Sales Ratio1.3
Price/Book Ratio3.09
Enterprise/Revenue1.82
Enterprise/EBITDA52.22

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.02
Operating Margin-0.01
AD

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.04

Income Statement

Revenue2.71B
Revenue/Share10.5
Gross Profit943.63M
EBITDA149.36M
Net Income-98.33M
Diluted EPS-0.34

Balance Sheet

Total Cash285.84M
Total Cash/Share1
Total Debt1.86B
Total Debt/Equity1.47
Current Ratio0.93
Book Value Per Share5.89

Price History

52-Week Change-32.73
52-Week High32.27
52-Week Low13.36
Moving Average 50 Days15.56
Moving Average 200 Days18.59

Statistics

Average Volume16.92M
Shares Outstanding285.46M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.07
Trailing Annual Dividend Yield0.51
Payout Ratio-1.21
Last Split Factor13:10
Last Split DateMay 19, 2017
AD